1. P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTITHYMOCYTE GLOBULIN (ATG) AS GVHD PROPHYLAXIS FOR MATCHED UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Dachy, F.; Furst, S.; Calmels, B.; Pagliardini, T.; Harbi, S.; Bouchacourt, B.; Calleja, A.; Lemarie, C.; Collignon, A.; Morel, G.; Legrand, F.; Bekrieva, E.; Granata, A.; Weiller, P. J.; Chabannon, C.; Schiano de Collela, J. M.; Vey, N.; Blaise, D.; Devillier, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WHO UNDERWENT PERIPHERAL BLOOD HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OR HIGH RISK MYELODYSPLASTIC SYNDROME. (23rd June 2022) Authors: Harbi, S.; Brac de la perriere, L.; Garciaz, S.; Pagliardini, T.; Calmels, B.; Cecile, M.; Hicheri, Y.; Bouchacourt, B.; Calleja, A.; Dachy, F.; Fürst, S.; Lemarie, C.; Braticevic, C.; Morel, G.; Legrand, F.; Bekrieva, E.; Granata, A.; Weiller, P. J.; Chabannon, C.; Vey, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗